Verve Therapeutics
VERV
#5987
Rank
$0.99 B
Marketcap
$11.13
Share price
0.00%
Change (1 day)
124.85%
Change (1 year)

Verve Therapeutics (VERV) - Total debt

Total debt on the balance sheet as of March 2025 : $68.63 Million USD

According to Verve Therapeutics's latest financial reports the company's total debt is $68.63 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Verve Therapeutics - Total debt on balance sheet (from 2020 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$69.98 M-6.57%
2023-12-31$74.9 M-8.56%
2022-12-31$81.91 M4090.18%
2021-12-31$1.95 M
2020-12-31N/A